共 50 条
- [2] Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation [J]. PHARMACOTHERAPY, 2019, 39 (02): : 196 - 203
- [7] Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US) [J]. Advances in Therapy, 2021, 38 : 3771 - 3788
- [10] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):